Imagine fixing a leaky pipe in your wall without tearing down the whole room. Instead of opening the chest and stopping the heart, this tool uses a laser and a special clip to connect blood vessels through a tiny hole. It removes the need for a heart-lung machine and tedious stitching, making the process much faster and safer.
Traditional open-heart surgery is high-risk, expensive, and requires long recovery times due to the need for heart-lung machines and chest-opening incisions.
The Elana Anastomotic System®, a laser-assisted device and innovative clip that enables non-occlusive mechanical coronary anastomosis without suturing.
If you are a surgical instrument manufacturer dealing with the high complexity of traditional CABG tools — this project developed the Elana Anastomotic System® that replaces manual suturing with a laser-assisted clip. This allows for a standardized procedure that reduces technical errors.
If you are a private cardiac clinic dealing with long patient recovery times and high risk of complications — this project developed a keyhole surgery method that avoids heart arrest. This can reduce direct healthcare costs of procedures by over 50%.
If you are a medical insurance provider dealing with the high cost of open-heart surgery and post-operative complications — this project developed a minimally invasive bypass that shortens recovery times. This leads to a reduction in direct healthcare costs by over 50%.
The ELANA® technology is expected to reduce direct healthcare costs of coronary artery bypass grafting (CABG) procedures by over 50%.
Based on available project data, the project is currently in the clinical validation phase to accelerate market entry by 2025.
The system is branded as the Elana Anastomotic System® and is being developed by AMT Medical Research BV, though specific licensing terms are not detailed in the text.
The project aims to accelerate market entry to 2025 through clinical validation and market authorization activities.
It replaces the need for a heart-lung machine and manual suturing, allowing for a 'keyhole' approach that can be performed without stopping the heart.
The project is led by AMT Medical Research BV, a Dutch SME, with a 100% industry ratio consisting of 2 SME partners. This lean, industry-focused structure suggests a strong drive toward commercialization rather than academic research, supported by a total funding target of €7.5M (combining a €2.5M grant and €5M equity).
Contact AMT Medical Research BV in the Netherlands
Contact us to explore licensing opportunities for the Elana Anastomotic System®
